Frontiers in Medicine | Regulatory Science

Original Research

Published on 29 Apr 2022

Assessment of Knowledge Regarding Safety Profile, Use, and Boxed Warnings of Fluoroquinolones Among Healthcare Professionals in Saudi Arabia: A Potential Implication for Drug Regulatory Authorities

in Regulatory Science

Tauqeer Hussain Mallhi
Abdullah Salah Alanazi
Yusra Habib Khan
Nasser Hadal Alotaibi
Muhammad Salman
Abdulaziz Ibrahim Alzarea
Salah-Ud-Din Khan
Nabil K. Alruwaili
Alaa Salah Alenazi
Ahmed D. Alatawi

Frontiers in Medicine

doi 10.3389/fmed.2022.816320

3,886 views
2 citations

Systematic Review

Published on 27 Apr 2022

Non-Pharmacological Interventions for Minimizing Physical Restraints Use in Intensive Care Units: An Umbrella Review

in Regulatory Science

Nianqi Cui
Xiaoli Yan
Yuping Zhang
Dandan Chen
Hui Zhang
Qiong Zheng
Jingfen Jin

Frontiers in Medicine

doi 10.3389/fmed.2022.806945

10,788 views
11 citations

Brief Research Report

Published on 26 Apr 2022

Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond

in Regulatory Science

Natalie M. Hendrikse
Jordi Llinares Garcia
Thorsten Vetter
Anthony J. Humphreys
Falk Ehmann

Frontiers in Medicine

doi 10.3389/fmed.2022.878942

6,124 views
14 citations

Original Research

Published on 25 Apr 2022

Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward

in Regulatory Science

Tariro Sithole
Gugu Mahlangu
Stuart Walker
Sam Salek

Frontiers in Medicine

doi 10.3389/fmed.2022.898725

5,204 views
9 citations

Original Research

Published on 25 Apr 2022

Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward

in Regulatory Science

Tariro Sithole
Gugu Mahlangu
Stuart Walker
Sam Salek

Frontiers in Medicine

doi 10.3389/fmed.2022.898743

4,340 views
14 citations

Policy Brief

Published on 15 Apr 2022

Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan

in Regulatory Science

Hideki Maeda
Daniel Bin Ng

Frontiers in Medicine

doi 10.3389/fmed.2022.864960

9,449 views
6 citations

Original Research

Published on 30 Mar 2022

Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea

in Regulatory Science

Kyung-Bok Son
Sylvia Park

Frontiers in Medicine

doi 10.3389/fmed.2022.869262

2,493 views
1 citation

Original Research

Published on 28 Mar 2022

Medication Errors and Type 2 Diabetes Management: A Qualitative Exploration of Physicians' Perceptions, Experiences and Expectations From Quetta City, Pakistan

in Regulatory Science

Muhammad Kashif Habib
Muhammad Naeem Khan
Abdul Sadiq
Qaiser Iqbal
Abdul Raziq
Nafees Ahmad
Zaffar Iqbal
Sajjad Haider
Muhammad Anwar
Fazal ur Rehman Khilji

Frontiers in Medicine

doi 10.3389/fmed.2022.846530

4,559 views
5 citations

Perspective

Published on 22 Mar 2022

Bioethics and COVID-19: Considering the Social Determinants of Health

in Regulatory Science

Luca Valera
Rodrigo López Barreda

Frontiers in Medicine

doi 10.3389/fmed.2022.824791

4,279 views
3 citations

Original Research

Published on 09 Mar 2022

Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging

in Regulatory Science

Liese Barbier
Allary Mbuaki
Steven Simoens
Paul Declerck
Arnold G. Vulto
Isabelle Huys

Frontiers in Medicine

doi 10.3389/fmed.2022.820755

13,445 views
27 citations

Original Research

Published on 02 Mar 2022

The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes

in Regulatory Science

Solomon Owusu Sekyere
Ivana Škrnjug-Yudov
Alexander Pinz
Heidi Meyer
Christoph Conrad

Frontiers in Medicine

doi 10.3389/fmed.2022.772605

2,938 views
1 citation

Brief Research Report

Published on 02 Mar 2022

An Infodemic of Misinformation on Stem Cell Therapy Among the Population of Saudi Arabia: A Cross-Sectional Study

in Regulatory Science

Doaa Aboalola
Heba Badraiq
Rawiah Alsiary
Samer Zakri
Neda Aboulola
Loay Haneef
Dalal Malibari
Moayad Baadhaim
Khaled Alsayegh

Frontiers in Medicine

doi 10.3389/fmed.2022.789695

4,335 views
6 citations

Original Research

Published on 25 Feb 2022

Panic, Psycho-Behavioral Responses, and Risk Perception in the Earliest Stage of the COVID-19 Pandemic in China

in Regulatory Science

Weiyu Zhang
Changqing Zou
Kristin K. Sznajder
Can Cui
Jiahui Fu
Shan He
Qinqi Peng
Qiongli Chen
Xiaoshi Yang

Frontiers in Medicine

doi 10.3389/fmed.2022.766842

2,418 views
4 citations

Perspective

Published on 18 Feb 2022

Establishing a Public Resource for Acceptable Surrogate Endpoints to Support FDA Marketing Applications

in Regulatory Science

Abena S. Agyeman
Jeffrey N. Siegel
Christopher Leptak

Frontiers in Medicine

doi 10.3389/fmed.2022.820990

3,409 views
4 citations

Original Research

Published on 17 Feb 2022

Orphan Drug Prices and Epidemiology of Rare Diseases: A Cross-Sectional Study in Italy in the Years 2014–2019

in Regulatory Science

Federico Villa
Aurora Di Filippo
Andrea Pierantozzi
Armando Genazzani
Antonio Addis
Gianluca Trifirò
Agnese Cangini
Giovanni Tafuri
Daniela Settesoldi
Francesco Trotta

Frontiers in Medicine

doi 10.3389/fmed.2022.820757

8,544 views
13 citations

Study Protocol

Published on 15 Feb 2022

A Protocol of a Guideline to Establish the Evidence Ecosystem of Acupuncture

in Regulatory Science

Qin Wang
Nian Li
Juan Li
Ying He
Yuxi Li
Dongling Zhong
Xiaobo Liu
Jin Fan
Rongjiang Jin
Deying Kang

Frontiers in Medicine

doi 10.3389/fmed.2021.711197

3,639 views
10 citations